| Product Name |
MF |
CAS |
Details |
| ELEDOISIN-RELATED PEPTIDE |
C34H58N8O6S |
2990-43-4 |
|
| FOR-MET-ALA-SER-OH |
C12H21N3O6S |
17351-32-5 |
|
| TETRABUTYLTIN |
C16H36Sn |
1461-25-2 |
|
| 6-METHOXY-1,2,3,4-TETRAHYDRO-ISOQUINOLINE |
C10H13NO |
42923-77-3 |
|
| NEUROMEDIN N |
C38H63N7O8 |
92169-45-4 |
|
| NEUROKININ B |
C55H79N13O14S2 |
86933-75-7 |
|
| 4-Ethyl-5-fluoro-6-hydroxypyrimidine |
C6H7FN2O |
137234-87-8 |
|
| 2-(3-(1-Benzylpiperidin-4-yl)-2-oxopropyl)-4,5-diMethoxybenzoic Acid (Donepezil IMpurity) |
C24H29NO5 |
197010-25-6 |
|
| NEUROPEPTIDE Y (3-36) (PORCINE) |
C176H271N53O54 |
143863-88-1 |
|
| N-methyl-2-sulfanylbenzamide |
C8H9NOS |
20054-45-9 |
|
| 2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate |
C11H13F3O5S |
160969-03-9 |
|
| CETUXIMAB |
C107H179N35O36S7 |
205923-56-4 |
|
| BENZOIC ACID, 5-IODO-2-METHYL-, METHYL ESTER |
C9H9IO2 |
103440-54-6 |
|
| 3-Bromocinnamaldehyde |
C9H7BrO |
97985-66-5 |
|
| ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-NLE-NH2 |
C64H100N18O13 |
57462-42-7 |
|
| ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-NLE-NH2 |
C64H100N18O13 |
57462-42-7 |
|
| 2-AMINO-5-CHLORO-4-METHYL-3-NITROPYRIDINE |
C6H6ClN3O2 |
148612-17-3 |
|
| PHI-27 (RAT) |
C136H216N36O41 |
96849-38-6 |
|
| 4-Bromoquinazoline |
C8H5BrN2 |
354574-59-7 |
|
| Epristeride |
C25H37NO3 |
119169-78-7 |
|
| 2-HEXYLOCTANOIC ACID |
C14H28O2 |
60948-91-6 |
|
| H-PRO-HIS-PRO-PHE-HIS-PHE-PHE-VAL-TYR-LYS-OH |
C69H87N15O12 |
75645-19-1 |
|
| 5-Bromoacetyl-2-hydroxybenzaldehyde |
C9H7BrO3 |
115787-50-3 |
|
| 1,2,3,4-TETRAHYDROQUINOLIN-6-OL |
C9H11NO |
3373-00-0 |
|
| 2,2-Di(tert-butylperoxy)butane |
C12H26O4 |
2167-23-9 |
|
| ILOPERIDONE |
C24H27FN2O4 |
133454-47-4 |
|
| COLIVELIN |
C119H206N32O35 |
867021-83-8 |
|
| 2-ethylphenyl isothiocyanate |
C9H9NS |
19241-19-1 |
|
| ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-MET-OME |
C64H99N17O14S |
76260-78-1 |
|
| dibromo[1,1'-bis(diphenylphosphino)ferrocene]palladium(II) |
C34H24Br2FeP2Pd |
124268-93-5 |
|
| NICKEL(II) FLUORIDE TETRAHYDRATE |
F2H8NiO4 |
13940-83-5 |
|
| H-PRO-LEU-SER-ARG-THR-LEU-SER-VAL-ALA-ALA-LYS-LYS-OH |
C56H103N17O16 |
105802-84-4 |
|
| H-LEU-LEU-TYR-GLU-MET-LEU-ALA-GLY-GLN-ALA-PRO-PHE-GLU-GLY-GLU-ASP-GLU-ASP-GLU-LEU-PHE-GLN-SER-ILE-MET-GLU-HIS-ASN-VAL-NH2 |
C148H221N35O50S2 |
122613-29-0 |
|
| 2,3-Dimethylphenyl isothiocyanate |
C9H9NS |
1539-20-4 |
|
| 3,4-dimethoxyphenyl isothiocyanate |
C9H9NO2S |
33904-04-0 |
|
| 3,4-Dimethylphenyl isothiocyanate |
C9H9NS |
19241-17-9 |
|
| ALPHA-METHYL-P-[1-OXO-2-ISOINDOLINYL]-BENZENEACETIC ACID |
C17H15NO3 |
31842-01-0 |
|
| 2,5-Dimethoxyphenethylamine hydrochloride |
C10H16ClNO2 |
3166-74-3 |
|
| N2-Acetyl-L-lysyl-L-alpha-aspartyl-L-valyl-L-tyrosine |
C26H39N5O9 |
757942-88-4 |
|
| Octadecanedioic acid, 1-methyl ester |
C19H36O4 |
72849-35-5 |
|
| CHROMIUM POTASSIUM SULFATE |
Cr2(SO4)3.xH2O |
15244-38-9 |
|
| Hydrocortisone 21-hemisuccinate |
C25H34O8 |
2203-97-6 |
|
| L-SELENOCYSTINE |
C6H12N2O4Se2 |
29621-88-3 |
|
| ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE-HIS-LEU-VAL-ILE-HIS-ASN |
C83H122N24O19 |
104180-23-6 |
|
| (R)-(-)-1-[(S)-2-(DI(3,5-DIMETHYL-4-METHOXYPHENYL)PHOSPHINO)FERROCENYL]ETHYLDICYCLOHEXYLPHOSPHINE |
C42H50FeO2P2 |
360048-63-1 |
|
| SYSTEMIN |
C85H144N26O28S |
137181-56-7 |
|
| H-HIS-CYS-LEU-GLY-LYS-TRP-LEU-GLY-HIS-PRO-ASP-LYS-PHE-OH |
C72H104N20O16S |
131334-43-5 |
|
| 4-Chloro-6-ethyl-5-fluoropyrimidine |
C6H6ClFN2 |
137234-74-3 |
|
| 5-AMINO-NAPHTHALENE-1-CARBOXYLIC ACID |
C11H9NO2 |
32018-88-5 |
|
| 5-ACETYL-2-NORBORNENE |
C9H12O |
5063-03-6 |
|
| Remdesivir impurity2 |
C33H31N5O4 |
1355357-49-1 |
|
| GRANULIBERIN R |
C69H103N19O14 |
64704-41-2 |
|
| D-PRO-GLN-GLN-D-TRP-PHE-D-TRP-LEU-MET-NH2 |
C57H75N13O10S |
81039-85-2 |
|
| Bromo-PEG5-t-butyl ester |
C17H33BrO7 |
1415800-38-2 |
|
| 4-bromo-6-tert-butyldibenzo[b,d]furan |
C16H15BrO |
1438391-33-3 |
|
| Remdesivir |
C27H35N6O8P |
1809249-37-3 |
|
| GASTRIN I (1-14) (HUMAN) |
C79H100N16O27 |
100940-57-6 |
|
| Bis[2,4-dimethyl-6-(7-methyl-1-isoquinolinyl)phenyl](2,4-pentanedionato)iridium |
C41H39IrN2O2 |
1056875-79-6 |
|
| (Acetylacetonato)bis(2,3,5-triphenylpyrazinato)iridium(III) |
C49H37IrN4O2 |
950984-35-7 |
|
| tert-Butyl 3-oxoazetidine-1-carboxylate |
C8H13NO3 |
398489-26-4 |
|
| 4-Phenylphenacyl chloride |
C14H11ClO |
635-84-7 |
|
| 1,2-DIANILINOETHANE |
C14H16N2 |
150-61-8 |
|
| POLY(STYRENE-CO-DIVINYLBENZENE) |
（C9H11N·C8H8)x |
89551-24-6 |
|
| PHYSALAEMIN |
C58H84N14O16S |
2507-24-6 |
|
| ANGIOTENSINOGEN (1-14) (RAT) |
C89H123N21O21 |
110200-37-8 |
|
| (2R,3R,4R,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)tetrahydrofuran-2-ol |
C32H32N4O5 |
1911578-73-8 |
|
| (D-PRO4,D-TRP7,9,10)-SUBSTANCE P (4-11) |
C62H74N14O10S |
86917-57-9 |
|
| H-D-TYR-ILE-ASN-LEU-ILE-D-THR-ARG-GLN-ARG-D-TYR-NH2 |
C61H99N19O15 |
163887-48-7 |
|
| H-D-TYR-ILE-ASN-LEU-ILE-D-THR-ARG-GLN-ARG-D-TYR-NH2 |
C61H99N19O15 |
163887-48-7 |
|
| Travoprost |
C26H35F3O6 |
157283-68-6 |
|
| PYR-GLN-PHE-N-ME-PHE-SAR-LEU-MET-NH2 |
C43H61N9O9S |
77128-69-9 |
|
| Diisononyl phthalate |
C26H42O4 |
28553-12-0 |
|
| TUFTSIN |
C21H40N8O6 |
9063-57-4 |
|
| POTASSIUM HEXACHLOROPLATINATE(IV) |
Cl6K2Pt |
1307-80-8 |
|
| PEPTIDE YY, HUMAN |
C194H295N55O57 |
118997-30-1 |
|
| TERT-BUTYL 6-HYDROXY-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXYLATE |
C14H19NO3 |
158984-83-9 |
|
| TERT-BUTYL 6-HYDROXY-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXYLATE |
C14H19NO3 |
158984-83-9 |
|
| MAGNESIUM SALICYLATE |
C14H10MgO7 |
18917-95-8 |
|
| H-ARG-PHE-TYR-VAL-VAL-MET-TRP-LYS-OH |
C56H81N13O10S |
149234-04-8 |
|
| 2-Bromoheptane |
C7H15Br |
1974-04-5 |
|
| 3,5-DIBROMO-4-METHYLPHENOL |
C7H6Br2O |
13979-81-2 |
|
| 7-BROMO-1H-INDOLE-3-CARBALDEHYDE |
C9H6BrNO |
115666-21-2 |
|
| CALCIUM-LIKE PEPTIDE |
C40H75N9O10 |
145224-99-3 |
|
| DYNORPHIN A (1-11) AMIDE |
C63H104N22O12 |
79985-48-1 |
|
| SODIUM METABORATE TETRAHYDRATE |
BH8NaO6 |
10555-76-7 |
|
| UROCORTIN (RAT) |
C206H338N62O64 |
171543-83-2 |
|
| [D-PRO2, D-TRP7,9]-SUBSTANCE P |
C74H106N20O13S |
80434-86-2 |
|
| DICHLOROTRIS(1,10-PHENANTHROLINE)RUTHENIUM(II) HYDRATE |
C36H36Cl2N6O6Ru |
207802-45-7 |
|
| CP-456773 sodium |
C20H23N2NaO5S |
256373-96-3 |
|
| KINETENSIN |
C56H85N17O11 |
103131-69-7 |
|
| H-ARG-PRO-GLY-PRO-PRO-GLY-LEU-GLN-GLY-ARG-LEU-GLN-ARG-LEU-LEU-GLN-ALA-ASN-GLY-ASN-HIS-ALA-ALA-GLY-ILE-LEU-THR-MET-NH2 |
C126H215N45O34S |
202801-92-1 |
|
| 1-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole |
C16H23N3O |
110693-63-8 |
|
| HO-PEG10-tBu |
C27H54O13 |
778596-26-2 |
|
| MOTILIN (CANINE) |
C120H194N36O34 |
85490-53-5 |
|
| 1003562-42-2 |
C111H81IrN9O12 |
Bis(2-phenylpyridine)(3-(pyridin-2-yl)-2H-chroMen- |
|
| Bis(2-phenylpyridine)(3-(pyridin-2-yl)-2H-chroMen-2-onate)iridiuM(III) |
C111H81IrN9O12 |
1003562-42-2 |
|
| H-ARG-ARG-LEU-SER-SER-LEU-ARG-ALA-OH |
C39H75N17O11 |
93674-74-9 |
|
| H-ASP-PHE-OH |
C13H16N2O5 |
13433-09-5 |
|
| PLATINUM(IV) SULFIDE |
PtS2 |
12038-21-0 |
|
| PLATINUM(IV) SULFIDE |
PtS2 |
12038-21-0 |
|
